Occasional Digest

FDA approves Telix brain cancer imaging drug Pixclara (TLX:NASDAQ)

Magnetic resonance imaging (MRI) or CT scan of the brain, sinusitis, sinonasal mass, brain tumours. Metastasis.

Md Babul Hosen/iStock via Getty Images

The Food and Drug Administration approved Telix Pharmaceuticals’ (TLX) Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the company said Sunday.

Pixclara, also known as floretyrosine F 18, is approved for use with positron emission tomography to help

Source link

Exit mobile version